Rankings
▼
Calendar
MLYS
Mineralys Therapeutics, Inc.
$2B
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$7M
EPS (Diluted)
$-1.40
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$16,000
Balance Sheet
Total Assets
$11M
Total Liabilities
$34M
Stockholders' Equity
-$23M
Cash & Equivalents
$11M
← FY 2021
All Quarters
Q1 2022 →
MLYS Q4 2021 Earnings — Mineralys Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
